With domestic drugmaker AstraZeneca among the companies leading the charge to produce COVID-19 vaccines, the U.K. was well positioned for a quick rollout. But after a successful first few months of vaccinations, the campaign has slowed as AstraZeneca’s primary manufacturing partner, the Serum Institute of India, has been forced to withhold exports as India deals with… Read More »
With plans to take its consumer healthcare joint venture with Pfizer public in the next few years, GlaxoSmithKline has been in Marie Kondo mode for some of its expansive global assets. After cutting a Canadian plant with 400 workers earlier this year, GSK is now hiving off an even bigger facility in Poland. GSK has sold… Read More »
GlaxoSmithKline has reportedly worked in recent months to shake up its antibiotics business after at least one failed attempt to divest products. Now, dozens of GSK employees could wind up on the cutting room floor as the drugmaker shifts away from producing a key antibiotic component. The British drugmaker will look to trim positions at… Read More »